Acute myeloid leukemia: Difference between revisions
No edit summary |
|||
| Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Acute myeloid leukemia medical therapy#Overview|Medical Therapy Overview]] | [[Acute myeloid leukemia medical therapy#Chemotherapy|Chemotherapy]] | [[Acute myeloid leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute myeloid leukemia medical therapy#Supportive Therapy|Supportive Therapy]] | [[Acute myeloid leukemia medical therapy#Overview|Medical Therapy Overview]] | [[Acute myeloid leukemia medical therapy#Chemotherapy|Chemotherapy]] | [[Acute myeloid leukemia medical therapy#Relapsed AML|Relapsed AML]] | [[Acute myeloid leukemia medical therapy#Supportive Therapy|Supportive Therapy]] | [[Acute myeloid leukemia primary prevention|Primary Prevention]] |[[Acute myeloid leukemia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute myeloid leukemia future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 13:49, 21 September 2012
Template:DiseaseDisorder infobox
|
Acute myeloid leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute myeloid leukemia On the Web |
|
American Roentgen Ray Society Images of Acute myeloid leukemia |
|
Risk calculators and risk factors for Acute myeloid leukemia |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Synonyms and keywords: AML; acute granulocytic leukaemia; acute myeloblastic leukemia; acute myelogenous leukemia
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Acute Myeloid Leukemia from Other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | Other Diagnostic Studies
Treatment
Medical Therapy Overview | Chemotherapy | Relapsed AML | Supportive Therapy | Primary Prevention |Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
External links